mesenchymal stem cells

[Human Cell] MSCs, a kind of multipotent stem cells with self-renewal ability and multi-differentiation ability, have become the “practical stem cells” for the treatment of diseases.

[Brooklyn ImmunoTherapeutics, Inc.] Brooklyn ImmunoTherapeutics, Inc. has announced that it had completed its acquisition of Novellus Therapeutics Limited. Novellus is developing next‑generation engineered MSC therapies using extensively patented mRNA-based cell reprogramming and gene editing technologies.

[Scientific Reports] Investigators compared the therapeutic potential of a novel drug candidate, NTG-101 to MSCs, including rat cartilage derived stem cells, bone marrow stem cells and human umbilical cord derived MSCs for the treatment of Degenerative Disc Disease.

[Scientific Reports] The authors set up a new natural scaffold deriving from a decellularized porcine mucoperiosteum, engineered by an innovative micro-perforation procedure based on Quantum Molecular Resonance and then subjected to in vitro recellularization with human bone marrow-derived mesenchymal stem cells.

[Stem Cell Research & Therapy] Scientists assessed the safety and efficacy of injecting intravenous Wharton’s jelly-derived MSCs in patients with COVID-19 as a treatment. Five patients with severe COVID-19 were treated with Wharton’s jelly-derived mesenchymal stem cells.

[Scientific Reports] Scientists found that IL-1β-stimulated human umbilical cord-derived mesenchymal stem cells enhanced the expression of membrane-bound and soluble tumor necrosis factor-related apoptosis-inducing ligand.